A spacer gif  
Healthcare, life science and biotech PR, marketing & design: De Facto Communications
Company Information Our Clients Practices Our Services The news section Our contact page
Our Team  

Our purpose is to build winning reputations for our clients and their brands. We achieve this by ensuring our senior management team is actively involved with every client and by delivering the best and most honest advice available. We say what we think and treat all our clients with an equal degree of attention, from early stage biotechs right through to global pharma and medical device companies.

As specialists in healthcare and life science communications, clinical trial marketing and
medical education, we have in-depth knowledge of the issues affecting your business. Based in London, we operate internationally through our Group offices in Europe and the US to help you reach the people you need to influence most.

Our medical education group offers you an expert team with deep insight into the complexities of what it takes to build a competitive reputation for a drug amongst the medical community. Their track record of success is based on their knowledge, influence and client-centred strategic advice, spanning all high profile therapeutic areas.

Bell Pottinger Group
In a complex and changing world, it is more important than ever to make the right communications choice to achieve the reputation you deserve.

De Facto is part of the Bell Pottinger Group, a refreshing alternative to the conventional. Our collection of 25 companies made up of public relations, corporate responsibility and design agencies, each with their own character and passion, is designed to collaborate. They have just one objective - to make our clients better known, better regarded and more successful.

Together we have the power to deliver the most contemporary answers to the most complex challenges. We have a reputation for delivering the most informed solutions - even for the most specialised audiences.

Our Partners:

Bell Pottinger Group


Communications Strategy Group